Replies to post #135530 on Biotech Values

[masterlongevity]

if these trials are successful and gammagard becomes an approved therapy for AD......

1) they will need to open many more collection centers, but still could not meet demand. If another DM drug launched it would gain the vast majority of market share

2) the price would need to be quite high. Again, if another DM drug launched, gammagard could not compete on price. it would need to be much more effective to get payors to cover.